SecBot SecBot
Insider Cluster (5 insiders) ·Filed Jun 10, 2026

MGX

Metagenomi Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 3 insiders, $0.0M total
Actionable Insight • Neutral

Insider sales are negligible in size and likely liquidity-driven. No bearish signal. Monitor for any upcoming material disclosures (e.g., pipeline updates, financing) that could affect the stock, but this cluster alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
MGX ▼ -4.88% at T+60d
NEUTRAL call -4.88% · α vs SPY -11.05% · entry $1.23 → $1.17
Entry = T+0 close
Jun 10, 2026
via day close
T+1d
+1.63%
call +1.63% · α -0.07%
$1.25
settled 5mo ago
T+5d
-7.32%
call -7.32% · α -10.75%
$1.14
settled 4mo ago
T+20d
+2.44%
call +2.44% · α -1.18%
$1.26
settled 4mo ago
T+60d
-4.88%
call -4.88% · α -11.05%
$1.17
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Three insiders at Metagenomi Therapeutics, including the CFO, sold a total of ~$9K in open-market sales on June 5, 2026. Two directors received non-cash stock grants on June 9. The dollar value of sales is trivial relative to the $46M market cap (~0.02%), and the cluster is not amplified by any material cross-filing context. This is routine insider activity with no actionable signal.

Key Financial Metrics

Direction
selling
Total Value
$9.3K
Insiders
5

Key Facts

  • CFO Pamela Wapnick sold 2,884 shares for ~$3,746 on June 5, 2026
  • Jian Irish sold 3,737 shares for ~$4,854 on June 5, 2026
  • Matthew Wein sold 558 shares for ~$725 on June 5, 2026
  • Two directors received non-cash stock grants of 21,000 shares each on June 9, 2026
  • Total open-market sales of ~$9K represent ~0.02% of $46M market cap
  • No material cross-filing context (e.g., earnings, offering, restatement) to amplify the cluster

Financial Impact

Total insider sales of ~$9K, or ~0.02% of market cap — immaterial

insider ownership

Risk Factors

  • Low liquidity and small market cap ($46M) make MGX susceptible to large price swings on any news

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
78% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MGX-1781200183945
14 reports for MGX
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +8.89%May 11, 2026
Filters
Rows
Reports for MGX — sortable, filterable
TypeNow
Sep 21, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$1.14 $0.8310▼ −27.11%▼ −26.55%$0.8000 (−29.82%)
Aug 10, 2026
11w ago
8-K
BEARISH ★ 5/10
$1.21 $1.15▲ +4.96%▲ +3.90%$0.8000 (+33.88%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8000 (−34.96%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8000 (−34.96%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8000 (−34.96%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8000 (−34.96%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8000 (−34.96%)
May 11, 2026
24w ago
8-K
NEUTRAL ★ 4/10
$1.35 $1.23▼ −8.89%▼ −7.16%$0.8000 (−40.74%)
May 11, 2026
24w ago
Press Release
BEARISH ★ 6/10
$1.35 $1.23▲ +8.89%▲ +7.16%$0.8000 (+40.74%)
Apr 27, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$1.44 $1.36▼ −5.56%▼ −11.02%$0.8000 (−44.44%)
Showing 10 of 14

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026